AKBA – Akebia Therapeutics Inc.
Name :
Sector :
Industry:
Mark. Cap: $0.0000
EPSttm :
Fair Value
Margin Of Safety %
Put/Call OI Ratio
0.25
Float Short %
9.54
EPS 1 Diff
-0.01
EPS Year Diff
0.04
Ticker: AKBA
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2024-09-06 | AKBA | 1.35 | 0.22 | 0.00 | 26641 |
| 2024-09-09 | AKBA | 1.411 | 0.22 | 0.00 | 26716 |
| 2024-09-10 | AKBA | 1.49 | 0.22 | 0.01 | 26740 |
| 2024-09-11 | AKBA | 1.45 | 0.22 | 8.57 | 27225 |
| 2024-09-12 | AKBA | 1.43 | 0.21 | 0.00 | 27112 |
| 2024-09-13 | AKBA | 1.455 | 0.22 | 0.10 | 26482 |
| 2024-09-16 | AKBA | 1.39 | 0.22 | 0.00 | 26342 |
| 2024-09-17 | AKBA | 1.38 | 0.22 | 0.04 | 26295 |
| 2024-09-18 | AKBA | 1.35 | 0.22 | 4.80 | 26423 |
| 2024-09-19 | AKBA | 1.37 | 0.24 | 0.08 | 26905 |
| 2024-09-20 | AKBA | 1.4 | 0.23 | 0.00 | 27120 |
| 2024-09-23 | AKBA | 1.305 | 0.24 | 0.01 | 25819 |
| 2024-09-24 | AKBA | 1.34 | 0.25 | 0.15 | 25179 |
| 2024-09-25 | AKBA | 1.32 | 0.25 | 0.00 | 25274 |
| 2024-09-26 | AKBA | 1.32 | 0.25 | 0.04 | 25273 |
| 2024-09-27 | AKBA | 1.32 | 0.25 | 4.13 | 25316 |
| 2024-09-30 | AKBA | 1.315 | 0.25 | 0.00 | 25451 |
| 2024-10-01 | AKBA | 1.28 | 0.25 | 0.42 | 25444 |
| 2024-10-02 | AKBA | 1.33 | 0.25 | 1.72 | 25581 |
| 2024-10-03 | AKBA | 1.33 | 0.25 | 0.05 | 25676 |
| 2024-10-04 | AKBA | 1.33 | 0.25 | 0.00 | 25678 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2024-09-06 | AKBA | 1.35 | 25.0 | - | -0.24 |
| 2024-09-09 | AKBA | 1.41 | 25.0 | - | -0.24 |
| 2024-09-10 | AKBA | 1.48 | 25.0 | - | -0.24 |
| 2024-09-11 | AKBA | 1.45 | 25.0 | - | -0.24 |
| 2024-09-12 | AKBA | 1.43 | 25.0 | - | -0.24 |
| 2024-09-13 | AKBA | 1.45 | 25.0 | - | -0.24 |
| 2024-09-16 | AKBA | 1.39 | 25.0 | - | -0.24 |
| 2024-09-17 | AKBA | 1.37 | 25.0 | - | -0.24 |
| 2024-09-18 | AKBA | 1.35 | 25.0 | - | -0.24 |
| 2024-09-19 | AKBA | 1.36 | 25.0 | - | -0.24 |
| 2024-09-20 | AKBA | 1.36 | 25.0 | - | -0.24 |
| 2024-09-23 | AKBA | 1.31 | 25.0 | - | -0.24 |
| 2024-09-24 | AKBA | 1.34 | 25.0 | - | -0.24 |
| 2024-09-25 | AKBA | 1.33 | 25.0 | - | -0.24 |
| 2024-09-26 | AKBA | 1.33 | 25.0 | - | -0.24 |
| 2024-09-27 | AKBA | 1.33 | 25.0 | - | -0.24 |
| 2024-09-30 | AKBA | 1.32 | 25.0 | - | -0.24 |
| 2024-10-01 | AKBA | 1.27 | 25.0 | - | -0.24 |
| 2024-10-02 | AKBA | 1.34 | 25.0 | - | -0.24 |
| 2024-10-03 | AKBA | 1.32 | 25.0 | - | -0.24 |
| 2024-10-04 | AKBA | 1.34 | 25.0 | - | -0.24 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2024-09-06 | AKBA | -0.69 | -8.77 | 9.49 |
| 2024-09-09 | AKBA | -0.69 | -8.77 | 9.49 |
| 2024-09-10 | AKBA | -0.69 | -8.77 | 9.49 |
| 2024-09-11 | AKBA | -0.69 | -8.77 | 9.49 |
| 2024-09-12 | AKBA | -0.69 | -8.77 | 9.55 |
| 2024-09-13 | AKBA | -0.69 | -8.77 | 9.55 |
| 2024-09-16 | AKBA | -0.69 | -8.77 | 9.55 |
| 2024-09-17 | AKBA | -0.69 | -8.77 | 9.55 |
| 2024-09-18 | AKBA | -0.69 | -8.77 | 9.55 |
| 2024-09-19 | AKBA | -0.69 | -8.77 | 9.55 |
| 2024-09-20 | AKBA | -0.69 | -8.77 | 9.55 |
| 2024-09-23 | AKBA | -0.69 | -8.77 | 9.55 |
| 2024-09-24 | AKBA | -0.69 | -8.77 | 9.55 |
| 2024-09-25 | AKBA | -0.69 | -8.77 | 9.54 |
| 2024-09-26 | AKBA | -0.69 | -8.77 | 9.54 |
| 2024-09-27 | AKBA | -0.69 | -8.77 | 9.54 |
| 2024-09-30 | AKBA | -0.69 | -8.77 | 9.54 |
| 2024-10-01 | AKBA | -0.69 | -8.77 | 9.54 |
| 2024-10-02 | AKBA | -0.69 | -8.77 | 9.54 |
| 2024-10-03 | AKBA | -0.69 | -8.77 | 9.54 |
| 2024-10-04 | AKBA | -0.69 | -8.77 | 9.54 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.04
Avg. EPS Est. Current Quarter
-0.06
Avg. EPS Est. Next Quarter
-0.05
Insider Transactions
-0.69
Institutional Transactions
-8.77
Beta
0.77
Average Sales Estimate Current Quarter
44
Average Sales Estimate Next Quarter
51
Fair Value (Academic)
Quality Score
25
Growth Score
42
Sentiment Score
53
Actual DrawDown %
90.2
Max Drawdown 5-Year %
-98.2
Target Price
5.5
P/E
Forward P/E
PEG
P/S
1.6
P/B
P/Free Cash Flow
EPS
-0.2
Average EPS Est. Cur. Y
-0.24
EPS Next Y. (Est.)
-0.26
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-23.18
Relative Volume
0.41
Return on Equity vs Sector %
98.2
Return on Equity vs Industry %
107.9
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
stock quote shares AKBA – Akebia Therapeutics Inc. Stock Price stock today
news today AKBA – Akebia Therapeutics Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch AKBA – Akebia Therapeutics Inc. yahoo finance google finance
stock history AKBA – Akebia Therapeutics Inc. invest stock market
stock prices AKBA premarket after hours
ticker AKBA fair value insiders trading